1-8 of 8
May Hagiwara
Close
Sort by
Journal Articles

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Rafael Fonseca, MD, May Hagiwara, PhD, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Jacqueline Buchanan, Thomas Delea, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2211.
https://doi.org/10.1182/blood-2019-123743
Published: 2019
Journal Articles

Burden of Disease Progression in Patients with Multiple Myeloma Who Have Received at Least One Line of Therapy in the US

May Hagiwara, PhD, Thomas Delea, MBA, MSIA, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Rafael Fonseca, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2018-99-117230
Published: 2018
Journal Articles

Healthcare Utilization (HRU) and Costs Among Multiple Myeloma (MM) Patients (Pts) Receiving Second or Subsequent Line Treatment (Tx) with Carfilzomib (CAR) or Pomalidomide (POM)

Sumeet Panjabi, PhD, May Hagiwara, PhD, Thomas E. Delea, MSIA
Journal: Blood
Blood (2016) 128 (22): 2419.
https://doi.org/10.1182/blood.V128.22.2419.2419
Published: 2016
Journal Articles

Patterns of Medication Use in Patients with Relapsed and/or Refractory Multiple Myeloma

May Hagiwara, PhD, Aaron Moynahan, MA, Ze Cong, Yaozhu J. Chen, MPA, Emilie Duchesneau, BA, Dana Hurley, PharmD, MS, Thomas E. Delea, MSIA
Journal: Blood
Blood (2015) 126 (23): 4497.
https://doi.org/10.1182/blood.V126.23.4497.4497
Published: 2015
Journal Articles

Use of Chemotherapy and Same-Day Pegfilgrastim Prophylaxis in US Clinical Practice

Derek Weycker, PhD, Hongsheng Wu, PhD, May Hagiwara, PhD, Xiaoyan Li, PhD, Richard L Barron, MS
Journal: Blood
Blood (2014) 124 (21): 4825.
https://doi.org/10.1182/blood.V124.21.4825.4825
Published: 2014
Journal Articles

Retrospective, Nested, Case-Control Study of the Association between Transfusion Frequency and Potential Complications of Iron Overload in Patients with Myelodysplastic Syndrome and Other Acquired Hematopoietic Disorders.

Thomas E. Delea, May Hagiwara, Pradyumna D. Phatak
Journal: Blood
Blood (2006) 108 (11): 968.
https://doi.org/10.1182/blood.V108.11.968.968
Published: 2006
Journal Articles

Utilization and Costs of Deferoxamine in Patients with Thalassemia, Sickle-Cell Disease, or Myelodysplastic Syndrome Receiving Frequent Transfusions.

Thomas E. Delea, MSIA, May Hagiwara, PhD, Simu K. Thomas, PhD, Jean-Francois Baladi, MBA, Pradyumna D. Phatak, MD, Thomas D. Coates, MD
Journal: Blood
Blood (2005) 106 (11): 5583.
https://doi.org/10.1182/blood.V106.11.5583.5583
Published: 2005
Journal Articles

Cost of Major Bleeding Following Major Orthopedic Surgery.

Gerry Oster, PhD, Montserrat Vera-Llonch, MD, MPH, May Hagiwara, PhD
Journal: Blood
Blood (2004) 104 (11): 4061.
https://doi.org/10.1182/blood.V104.11.4061.4061
Published: 2004